Skip to Main Content
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 1
1 January 2003
Issue Cover
All Issues
EISSN 1424-9634
Issue Sections

Journal Archive

Cancer Immunology Research (2013-Present)

(ISSN 2326-6066) Published monthly since 2013.

Cancer Immunity (2001-2013; volumes 1-13)

(EISSN 1424-9634) Published periodically from 2001-2013.

 

Cancer Immunology Research, launched in 2013 with Glenn Dranoff as founding Editor-in-Chief, is published by the AACR. The Journal illuminates the interplay between tumors and the immune system, with Robert D. Schreiber and Philip D. Greenberg serving as the Editors-in-Chief.

Cancer Immunity was an open access, peer-reviewed journal of the Cancer Research Institute (CRI) that published laboratory and clinical research papers on the immune response to cancer until 2013. The AACR maintains the entire archive of Cancer Immunity on this web site as part of a collaboration between the CRI and the American Association for Cancer Research. Selected Cancer Immunity articles are also available as Collected Papers. CRI also promotes free access to a searchable online Peptide Database, which contains the most important and clinically relevant human tumor antigens.

Table of Contents

Cancer Immunity, an open access journal of the Cancer Research Institute

Articles

Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory
Jie Dai; Bei Liu; Marissa M. Caudill; Hong Zheng; Yi Qiao; Ekhard R. Podack; Zihai Li
View articletitled, Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory
Open the PDF for in another window
Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer
Huiming Zhang; Jonathan Melamed; Ping Wei; Karen Cox; Wendy Frankel; Robert R. Bahnson; Nikki Robinson; Ron Pyka; Yang Liu; Pan Zheng
View articletitled, Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer
Open the PDF for in another window
MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients
Joseph A. Mollick; F. Stephen Hodi; Robert J. Soiffer; Lee M. Nadler; Glenn Dranoff
View articletitled, MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients
Open the PDF for in another window
Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients
Axel Mischo; Andreas Wadle; Kristin Wätzig; Dirk Jäger; Elisabeth Stockert; Darren Santiago; Gerd Ritter; Evi Regitz; Elke Jäger; Alex Knuth; Lloyd Old; Michael Pfreundschuh; Christoph Renner
View articletitled, Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients
Open the PDF for in another window
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
Jonathan Cebon; Elke Jäger; Mark J. Shackleton; Peter Gibbs; Ian D. Davis; Wendie Hopkins; Sharen Gibbs; Qiyuan Chen; Julia Karbach; Heather Jackson; Duncan P. MacGregor; Sue Sturrock; Hilary Vaughan; Eugene Maraskovsky; Antje Neumann; Eric Hoffman; Mathew L. Sherman; Alexander Knuth
View articletitled, Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
Open the PDF for in another window
Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia
Li Li; Anita Schmitt; Peter Reinhardt; Jochen Greiner; Mark Ringhoffer; Bianca Vaida; Martin Bommer; Markus Vollmer; Markus Wiesneth; Hartmut Döhner; Michael Schmitt
View articletitled, Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia
Open the PDF for in another window
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease
Madhav V. Dhodapkar; Keren Osman; Julie Teruya-Feldstein; Daniel Filippa; Cyrus V. Hedvat; Kristin Iversen; Denise Kolb; Matthew D. Geller; Hani Hassoun; Tarun Kewalramani; Raymond L. Comenzo; Keren Coplan; Yao-Tseng Chen; Achim A. Jungbluth
View articletitled, Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease
Open the PDF for in another window
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer
Tetsuya Nakada; Yuji Noguchi; Shuichiro Satoh; Toshiro Ono; Takashi Saika; Takushi Kurashige; Sacha Gnjatic; Gerd Ritter; Yao-Tseng Chen; Elisabeth Stockert; Yasutomo Nasu; Tomoyasu Tsushima; Hiromi Kumon; Lloyd J. Old; Eiichi Nakayama
View articletitled, <em>NY-ESO-1</em> mRNA expression and immunogenicity in advanced prostate cancer
Open the PDF for in another window
In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts
Alena Donda; Valérie Cesson; Jean-Pierre Mach; Giampietro Corradin; F. James Primus; Bruno Robert
View articletitled, <em>In vivo</em> targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts
Open the PDF for in another window
Disease-driven T cell activation predicts immune responses to vaccination against melanoma
Daniel E. Speiser; Donata Rimoldi; Pascal Batard; Danielle Liénard; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero
View articletitled, Disease-driven T cell activation predicts immune responses to vaccination against melanoma
Open the PDF for in another window
SSX antigens as tumor vaccine targets in human sarcoma
Maha Ayyoub; Michelle Brehm; Geneviève Metthez; Susan Talbot; Valerie Dutoit; Robert N. Taub; Mary-Louise Keohan; Ali O. Gure; Yao-Tseng Chen; Barbara Williamson; Achim A. Jungbluth; Lloyd J. Old; Charles S. Hesdorffer; Danila Valmori
View articletitled, SSX antigens as tumor vaccine targets in human sarcoma
Open the PDF for in another window
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine
Danila Valmori; Valérie Dutoit; Maha Ayyoub; Donata Rimoldi; Philippe Guillaume; Danielle Liénard; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero; Daniel E. Speiser
View articletitled, Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine
Open the PDF for in another window
Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine
Lijie Wang; Yoshihiro Miyahara; Takuma Kato; Linan Wang; Takumi Aota; Kagemasa Kuribayashi; Hiroshi Shiku
View articletitled, Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine
Open the PDF for in another window
A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16
Valérie Vantomme; Pascale Boël; Etienne De Plaen; Thierry Boon; Pierre van der Bruggen
View articletitled, A new tumor-specific antigenic peptide encoded by <em>MAGE-6</em> is presented to cytolytic T lymphocytes by HLA-Cw16
Open the PDF for in another window
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2
Claudia Wagner; Frank Neumann; Boris Kubuschok; Evi Regitz; Axel Mischo; Stefan Stevanovic; Michael Friedrich; Werner Schmidt; Hans-Georg Rammensee; Michael Pfreundschuh
View articletitled, Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2
Open the PDF for in another window
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer
Padmanee Sharma; Sacha Gnjatic; Achim A. Jungbluth; Barbara Williamson; Harry Herr; Elisabeth Stockert; Guido Dalbagni; S. Machele Donat; Victor E. Reuter; Darren Santiago; Yao-Tseng Chen; Dean F. Bajorin; Gerd Ritter; Lloyd J. Old
View articletitled, Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer
Open the PDF for in another window

Editor’s View

Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer
Pramod K. Srivastava
View articletitled, Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer
Open the PDF for in another window

Commentary

The uterine cervix - a new member of the family of immunologically exceptional sites?
Petter Höglund; Klas Kärre; Georg Klein
View articletitled, The uterine cervix - a new member of the family of immunologically exceptional sites?
Open the PDF for in another window

Reflections

The winding road to the discovery of the SR/CR mice
Zheng Cui
View articletitled, The winding road to the discovery of the SR/CR mice
Open the PDF for in another window
  • Online ISSN 1424-9634

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept